Glioblastoma (GBM) Models

80+ GBM models preserving intact immune, vascular, and hypoxic TME. Validated for >4-week stability.

PDO 1.0 & 2.0

H&E, IF (Nestin, Olig2, S100B), FACS

Validated Applications:

  • TME-targeted drug evaluation
  • HIF-2α pathway targeting
  • Tumor killing assay by FACS